Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Margolin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cleveland Clinic Journal of Medicine|November 4, 2005
Depression in older patients with neurologic illness: causes, recognition, managementAlan Carson, Richard Margolin
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentNorhakim Yahya, Scott J Pollack, Richard Margolin, et al.
JAMA|June 12, 2003
Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS)E Wesley Ely, Brenda Truman, Ayumi Shintani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal dataMark E Schmidt, Ping Chiao, Gregory Klein, et al.
Alzheimer'S Research & Therapy|July 31, 2015
An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheterBrendan P Lucey, Celedon Gonzales, Ujjwas Das, et al.
Neurology|July 26, 2015
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trialsEnchi Liu, Mark E Schmidt, Richard Margolin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 15, 2018
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research RoundtableDavid S Knopman, Samantha Budd Haeberlein, Maria C Carrillo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cleveland Clinic Journal of Medicine|November 4, 2005
Depression in older patients with neurologic illness: causes, recognition, managementAlan Carson, Richard Margolin
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentNorhakim Yahya, Scott J Pollack, Richard Margolin, et al.
JAMA|June 12, 2003
Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS)E Wesley Ely, Brenda Truman, Ayumi Shintani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal dataMark E Schmidt, Ping Chiao, Gregory Klein, et al.
Alzheimer'S Research & Therapy|July 31, 2015
An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheterBrendan P Lucey, Celedon Gonzales, Ujjwas Das, et al.
Neurology|July 26, 2015
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trialsEnchi Liu, Mark E Schmidt, Richard Margolin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 15, 2018
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research RoundtableDavid S Knopman, Samantha Budd Haeberlein, Maria C Carrillo, et al.
Pageof 1